Genomic Classification and Prognosis in Acute Myeloid LeukemiaElli Papaemmanuil, Peter J. Campbell, Moritz Gerstung et al.|New England Journal of Medicine|2016Cited by 4.4k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> MutationRichard M. Stone, Hartmut Döhner, Gerhard Ehninger et al.|New England Journal of Medicine|2017Cited by 2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic LeukemiaFrancesco Lo‐Coco, Uwe Platzbecker, Giuseppe Avvisati et al.|New England Journal of Medicine|2013Cited by 1.6k
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney DiseaseDavid M. Good, Philippe Schmitt‐Kopplin, Petra Zürbig et al.|Molecular & Cellular Proteomics|2010Cited by 537
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AMLSabine Käyser, Konstanze Döhner, Jürgen Krauter et al.|Blood|2010Cited by 485